|
KPNA1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.886100E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.002200E-01 |
| Normal-vs-Stage2 |
4.052200E-01 |
| Normal-vs-Stage3 |
5.147600E-01 |
| Normal-vs-Stage4 |
6.363800E-01 |
| Stage1-vs-Stage2 |
5.188000E-01 |
| Stage1-vs-Stage3 |
7.114800E-01 |
| Stage1-vs-Stage4 |
6.926400E-01 |
| Stage2-vs-Stage3 |
7.993400E-01 |
| Stage2-vs-Stage4 |
8.549000E-01 |
| Stage3-vs-Stage4 |
7.741800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.885630E-01 |
| Normal-vs-AfricanAmerican |
2.249400E-01 |
| Normal-vs-Asian |
6.918600E-01 |
| Caucasian-vs-AfricanAmerican |
7.415600E-01 |
| Caucasian-vs-Asian |
9.709800E-01 |
| AfricanAmerican-vs-Asian |
8.783600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.114400E-01 |
| Normal-vs-Female |
3.856400E-03 |
| Male-vs-Female |
7.522500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.738400E-01 |
| Normal-vs-Extreme_Weight |
4.187400E-01 |
| Normal-vs-Obese |
1.775820E-01 |
| Normal-vs-Extreme_Obese |
8.813200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.502600E-01 |
| Normal_Weight-vs-Obese |
8.350400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.793600E-01 |
| Extreme_Weight-vs-Obese |
6.238400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.065200E-01 |
| Obese-vs-Extreme_Obese |
6.920000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.162610E-01 |
| Normal-vs-Age(41-60Yrs) |
1.451670E-02 |
| Normal-vs-Age(61-80Yrs) |
8.434400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.951400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.943400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.398000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.854400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.150400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.510400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.978800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.959500E-02 |
| Normal-VS-Type2 PRCC |
6.482600E-01 |
| Normal-VS-KIRP CIMP |
1.548820E-01 |
| Normal-VS-Unclassified PRCC |
1.998800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.862500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.357400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.608600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.381200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.241360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.059800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.450000E-01 |
| Normal-vs-N1 |
9.633800E-02 |
| Normal-vs-N2 |
6.369400E-01 |
| N0-vs-N1 |
2.502200E-02 |
| N0-vs-N2 |
5.801600E-01 |
| N1-vs-N2 |
7.800400E-01 |
|
|
